The skin/implant interface of osseointegrated (OI) implants is susceptible to infection, causing excess pain, increased morbidity, and possibly implant removal. Novel distal femoral OI implants with binary nitride coatings have been developed with little physiological modeling to collect microbiological evidence of resistance to bacterial attachment. This in vitro study evaluated a Ti-6Al-4V alloy coated with TiNbN and treated with low plasticity burnishing (LPB) to assess attachment and biofilm formation of methicillinresistant Staphylococcus aureus (MRSA) under physiologically modeling conditions compared to standard Ti-6Al-4V alloy materials with a polished ("Color Buff") or non-polished finish ("Satin Finish"). Washability of the materials were also assessed and compared. It was hypothesized that the TiNbN/LPB treatments would resist bacterial adhesion and biofilm formation to a greater degree than the other two materials, and have a higher degree of bacterial removal following a clinically relevant wash regimen. Material types were exposed to a constant flow of broth containing MRSA and were analyzed using bacterial quantification, surface coverage analysis, and SEM imaging. Quantification data showed no difference in bacterial attachment among the varying material types both with and without the wash regimen. Surface coverage and SEM analysis confirmed results. The wash regimen led to an approximately 3 log 10 reduction in bacteria for all material types. Though the results did not support the hypothesis that a TiNbN coating/LPB treatment might resist bacterial attachment/biofilm formation more than other alloys, or have less bacteria after cleaning, results did support the potential importance of a daily wound-hygiene regimen at the skin/implant interface of OI materials. Published 2018.
In the last two decades, percutaneous osseointegrated (OI) implants have been developed and used for aboveknee and above-elbow amputations in the United States, 1 the Netherlands, 2 Sweden, [3] [4] [5] [6] [7] [8] Germany, [9] [10] [11] [12] [13] and the UK 14, 15 to reduce the need for socket prostheses. Though promising and advantageous over traditional socket prostheses due to direct bone loading, the primary clinical concern with percutaneous OI devices remains the risk of infection, which jeopardizes their clinical success. 7 OI implants are at continual risk of contamination, which may derive from exogenous or hematogenous sources. The formation of biofilms has the potential to cause recurring, difficult-to-treat infections. These infections are not likely to heal spontaneously, but rather require long-term management. Biofilms may develop gradually over an implant surface, favoring the skin/implant interface (see Fig. 1 ) and other nonosseointegrated portions of the stoma resulting in adverse effects that can lead to implant removal, revision surgery, and residual limb shortening. 16, 17 Rates of infection that accompany limb OI implants in current clinical use are variable and range from 5 to 34%. 7, 18, 19 It has also been suggested that within the first two years of use, 100% of patients can expect to suffer from superficial infection at some point. 19, 20 In order to combat biofilm-related infections, many technologies have been developed including antimicrobial coatings [21] [22] [23] [24] and bioabsorbable sleeves that contain antimicrobials. 25 However, the efficacy of antibiotic treatment is declining, especially in the presence of biofilm, due to increased levels of antibiotic tolerance and resistance development with recurring antibiotic use. [26] [27] [28] [29] Another disadvantage of antimicrobial coatings is the eventual limit of antibiotic elution. Therefore, a promising potential to combat biofilm is to prevent it from adhering/forming on an implant surface initially, without antibiotic use, using a permanent surface modification. Several studies have shown that surface modifications of implants may decrease bacterial adhesion and biofilm formation, 26, 28, [30] [31] [32] thus the rationale for this study. Low energy surfaces have been shown to reduce the rate of bacterial colonization and biofilm formation in in vitro and in vivo investigations of OI dental materials. 33 In the last decade, in vivo studies have shown the potential of a low surface energy, nonabrasive, titanium niobium oxynitride ([Ti,Nb]ON) ceramic to increase strength of OI orthopaedic devices in the lower limb. The suggestion is that this material has potential to decrease abrasion against soft tissue and decrease clinically relevant infections. 13 However, microbiological evidence for the antimicrobial potential of the surface material alone is void in the literature.
The first goal of this in vitro investigation was to explore the ability of a low energy surface biomaterial coating, titanium niobium nitride (TiNbN), in combination with a low plasticity burnishing (LPB) procedure, to prevent bacterial adhesion and biofilm formation and compare outcomes to known biomaterials (e.g., plain TiAl6V4 alloy), which also constitute candidate materials for OI devices. The second goal was to determine if the TiNbN/LPB material might allow a greater degree of biofilm removal during a clinically relevant hygiene care procedure. It was hypothesized that the TiNbN/LPB material would resist bacterial adhesion/biofilm formation to the greatest degree, and have the highest degree of bioburden removal with a clinical washing procedure when compared to other common percutaneous orthopaedic material surface types used in OI devices.
The rationale for the TiNbN coating was two-fold. First, the TiNbN coating is similar in ceramic hardness and application to a Nb coating used in clinical trials in Germany in combination with operative soft tissue management at the skin-implant interface and a daily hygiene regimen. 13 Second, the use of TiNbN coating was consistent with approved material for surgical implants and had appropriate hardness characteristics desired for the application. This is marketed as Armorcoat on DJO products and had hydrophilic and tribological characteristics that seemed to aid in bio-adhesion resistance. 35, 36 The LPB procedure, used on the TiNbN coated sample, provided a surface enhancement that has been shown to improve fatigue strength and in some cases give the surface a near mirror finish. 37 The nature of the smooth finish motivated the hypothesis that less biofilm would form and be removed to a greater degree than biofilms on the other two material types.
This study was modeled after similar studies using an in vitro flow cell system that more closely modeled a physiological environment for biofilm growth on surfaces. 38, 39 The rationale for developing this system was first to reduce the variability of in vivo studies in order to focus solely on the surface material, and second to develop further support for use of a flow cell system to analyze bacterial growth on surface materials in a translational manner.
MATERIALS AND METHODS

OI Implant Materials and Machining
Six samples of three separate Ti-6Al-4V alloy surfaces were manufactured and machined at DJO Surgical. Samples were manufactured and machined to dimensions of 2.5 Â 2.5 Â 0.5 cm 3 . These dimensions allowed them to fit in the custom designed flow cell unit (Fig. 2) . The three surface types were 1) Ti-6A-4V treated with LPB and coated with TiNbN, 2) polished ("Color Buff") Ti-6Al-4V alloy and 3) non-polished ("Satin Finish") Ti-6Al-4V alloy. Only the TiNbN coated materials were treated with LPB.
For each sample that was machined, only one 2.5 Â 2.5 cm 2 face received one of the three treatments, thus that face was the region of interest for bacterial growth/ assessment. To avoid bacterial growth on the remaining surfaces, they were covered in paraffin wax prior to placement in a flow cell chamber. Following biofilm growth (detailed below), wax was aseptically removed so as to remove the bacteria from those regions where analysis was unwanted.
Surface Morphology, Roughness, and Contact Angle Prior to beginning experimentation on each sample type, the surfaces of interest were assessed qualitatively by collecting SEM images under secondary electron imaging (SEI) for surface irregularities and similarities between sample types. In addition, surface roughness average (Ra) of the three material types was determined by an independent company, E x ponent. Data were collected using white light interferometry on a Zygo New View 5000 following an internal standard operating procedure (SOP) of the company. Three areas on n ¼ 6 samples of each material type were measured. 
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Contact angle measurements were also determined with two liquids: Deionized H 2 O (BDH, ASTM Type II, Ca No. BDH1168) and 10% bovine serum (HyClone Wear Testing Fluid Ca No. RR14584.01) in PBS. ASTM standard D7334-08 was followed. Contact angles were measured by photo analysis after placing droplets of each fluid on the specimen surface at the moment of initial contact. For water, 8 ml were used and for bovine serum the volume was increased to 12 ml because of fluid adhesion to the needle.
Microbiology Supplies and Bacterial Isolate
Brain heart infusion (BHI) broth, phosphate buffered saline (PBS), tryptic soy broth (TSB) that was used to make tryptic soy agar (TSA), culture tubes, Petri dishes and general supplies were purchased from Fisher Scientific (Waltham, MA). Medical grade detergent was purchased from L&R Ultra Sonics (Kearny, NJ). Columbia blood agar was purchased from Hardy Diagnostics (Midvale, UT). Peristaltic pumps, accompanying tubing and connectors were purchased from Cole Parmer (Vernon Hills, IL). The sonicating toothbrush was a Philips Sonicare (Andover, MA). Paraformaldehyde and glutaraldehyde were purchased from Sigma Aldrich (St. Louis, MO). Paraffin wax was purchased from SurgiPath (Leica Biosystems Inc., Buffalo Grove, IL). The flow cell unit was custom designed and machined by the Chemistry Machine Shop at the University of Utah.
A clinically relevant isolate of MRSA collected from the knee of an infected patient, provided by ARUP Laboratories (Salt Lake City, UT), was used for this study. The patient developed an infection after undergoing arthroscopic surgery. This isolate has been confirmed to contain the icaADBC gene operon and has been used in previous studies confirming its pathogenic and biofilm-forming properties. 23, 40, 41 The isolate was stored at À80˚C and passaged no more than two times on TSA before each use.
Biofilm Formation
In order to determine the ability of the MRSA isolate to develop biofilms on each of the sample types, a custom flow cell system was used 38, 39 (Fig. 2) . The setup for the flow system began by adding 3L of a 10% BHI broth solution into a 4L Erlenmeyer flask. Tygon tubes were placed into the solution such that one end was immersed in the broth and the other end was free for connection to a peristaltic pump. The flask and tubes were autoclaved together to ensure the broth and tubes were sterile prior to inoculation. A 1.0 McFarland standard was made in PBS using the MRSA isolate. This resulted in a bacterial concentration of $1 Â 10 8 colony forming units (CFU)/ml (confirmation data not shown). Three milliliters of the 1.0 McFarland solution was added to the 3L of 10% BHI broth.
The bacterial solution was mixed thoroughly and had a final bacterial concentration of $1 Â 10 5 CFU/ml. The 4L Erlenmeyer flask was placed on ice outside of an incubator (Fig. 2) . By keeping the flask on ice, bacterial growth was prevented from occurring prematurely in the broth solution. The free ends of the Tygon tubes were situated in the peristaltic pump and connected to an inlet on the lid of a flow cell chamber such that broth could be flowed into each chamber and flow through an effluent outlet into a waste container (see Fig. 2 ). Samples were placed in individual chambers of the flow cell unit and submerged with noninoculated 10% BHI. The flow cell unit was placed in an incubator set to 37˚C and angled to an incline of $10˚to facilitate broth flow out of the outlet. The inoculated BHI from the 4L Erlenmeyer flask was pumped through each chamber at a rate of 4.5 ml/h for 72 h to allow biofilms to form. Initial experimental runs indicated that biofilms had not matured by 24 or 48 h (data not shown), but had formed into microcolonies and plumes by 72 h.
After growth, samples were subjected to one of six tests ( Fig. 3) : quantification of adhered bacteria, quantification of adhered bacteria post wash regimen, gross image surface coverage analysis, gross image surface coverage analysis post wash regimen, SEM imaging, or SEM imaging post wash regimen. All tests were assessed with n ¼ 6 samples/test except the SEM tests (n ¼ 3 samples/test). After each test, samples were scrubbed with detergent and a sonicating toothbrush, then further cleaned with acetone, and sterilized in an autoclave to be reused for the next experiment (Fig. 3) . Samples could not be reused after SEM imaging, thus those tests were performed last and only n ¼ 3 samples/test could be used.
Biofilm Quantification
Direct quantification using a 10-fold dilution series was performed to determine the CFU/cm 2 in biofilms that formed on each material similar to previous studies. 23, [39] [40] [41] This allowed a baseline of growth to be determined for each material type. To do so, each sample was aseptically removed from a flow cell chamber after growing biofilms as described above and rinsed three times in PBS. The paraffin wax that had been placed on the edges and bottom of each sample was removed using a sterile scalpel blade and sterile forceps, leaving the exposed surface undisturbed for analyses. Samples were placed in plastic falcon tubes containing 30 ml of PBS, vortexed for 1 min, sonicated for 10 min (at 42 kHz), and vortexed a final time for 10 s to break up biofilm and remove bacteria from the surface.
One-hundred microliters of solution were removed, a 10-fold dilution series was performed, and each dilution was plated on TSA. Plates were incubated at 37˚C overnight and the CFU/cm 2 determined the following day. Samples of the In the open chamber on the left, an OI sample has been placed inside to show how it was housed. The chamber on the right has the lid on to show the air filter, inlet that allowed broth to come into the chamber, the screws to secure the lid in place and the effluent port that allowed for flow of broth through the system. (B) Inoculated BHI broth was put in a 4L Erlenmeyer flask and kept on ice.
Tubing was situated through a peristaltic pump and connected to the flow cell system inside an incubator next to the pump.
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BHI in each flow cell chamber were also collected and quantified to confirm that each OI sample had been exposed to a similar bioburden.
Surface Coverage Analysis
Percent of surface coverage of developed biofilms on each surface type was analyzed, providing a macro view of biofilm growth. To do so, the same protocol as described above was used to grow biofilms, rinse samples, and remove wax. Samples were then fixed for $24 h in modified Karnovsky's fixative (2% paraformaldehyde, 2.5% glutaraldehyde in PBS, buffered to pH 7.2) that contained 0.1% ruthenium red. Following fixation, samples were dehydrated in 100% ethanol for $2 h then air-dried overnight. Digital photographs of each sample were collected using a high-resolution (>20MP) Nikon D7100 camera. Images were processed in Adobe Photoshop to contrast the ruthenium red stain (biofilm) with the background surface. A custom code was written in MatLab to analyze the % surface coverage of multilayered biofilms on the surface of each material type.
SEM Imaging
To prepare for SEM imaging, samples were subjected to the same fixation, and dehydration process as for surface coverage analysis. Samples were then coated with gold using a Hummer 7.2 sputter coater and imaged using a JEOL JSM 6610 SEM under SEI mode to qualitatively assess biofilm morphology at various magnifications.
Material Washability
In clinical practice, patients who have percutaneous OI implants are instructed to wash the implant/skin interface with mild soap and water twice daily. 13 It has been suggested that this practice prevents the formation of bacterial biofilms at the stoma in amputees. 13 To date, no direct observations have been presented of the effects that this washing practice has on biofilms that grow on OI material surfaces. Thus, the second component of the hypothesis was to test the ability of a clinically-relevant wash procedure to reduce the level of biofilm on the TiNbN/LPB surface compared to standard modifications.
To perform this test, biofilms were grown as outlined above. In order to determine the washability of each material type, that is, the ability for biofilms/bioburden to be removed, following flow cell exposure the samples were brushed with a badger hair brush lathered using a bar of Dove 1 sensitive skin soap and tap water. The badger brush was stroked backand-forth over the material surface 20 times within a period of $20 s. This modeled a realistic clinical time and level of scrub that is recommended to patients with percutaneous devices. Once washed, the samples were rinsed in running tap water and subjected to the same quantification (n ¼ 6), surface coverage (n ¼ 6), and SEM (n ¼ 3) testing. Data were collected for the sample sizes as indicated with the exception of the quantification of the Satin Finish samples, which only had n ¼ 5 repeats due to one of the chambers failing to have broth flow, and was not included in analysis.
Statistical Analysis
Quantification data were compared by performing a Log 10 transformation of the CFU counts and comparing means with a one-way ANOVA analysis with alpha level set at 0.05 and a Tukey post-hoc analysis. Surface coverage and Ra data were similarly compared.
RESULTS
Surface Material Morphology SEM images showed machining marks and morphologies of each material type (Fig. 4, ÀControl) . In the case of samples coated with TiNbN and treated with LPB, rugged crevices could be seen throughout the surface and had a noticeable pitted morphological appearance compared to the scratched Color Buff surface and the striated surface on the Satin Finish.
Ra data indicated that the roughest surface was that of the TiNbN/LPB samples (Table 1) . These data coincided with what was seen by SEM (see Fig. 4 , ÀControl). All of the Ra measurements were statistically significantly different between each material type (p ¼ 0.001). Contact angle data showed that all samples had similar outcomes (Table 1 ) and were not statistically significantly different between any of the groups (p ¼ 0.536). Furthermore, samples were completely submerged in fluid during the growth protocol and thus contact angle had no effect on bacterial exposure to the material. Sample processing progression. Biofilms were grown on samples and then subjected to one of four tests (step 2) (n ¼ 6/sample type). Samples were then cleaned, sterilized, and biofilm were grown again for another step 2 test. After all tests in step 2 were complete, samples were cleaned once more, biofilms were grown a final time, and SEM testing (step 5) was completed (n ¼ 3/sample type).
BIOFILM GROWTH/REMOVAL FROM OI MATERIALS
Biofilm Formation and Quantification Pre and Post Wash
For each test that was performed, wherein the 4L Erlenmeyer flask was inoculated initially with bacteria and kept on ice, data showed that the average CFU/ml of broth within the flask was 5.00 AE 0.11 Log 10 units.
The growth protocol that was used resulted in significant biofilm formation of MRSA on each of the three material types (Figs. 4 and 5, þControl) . SEM imaging confirmed that the wax prevented bacterial attachment on the untreated surfaces (data not shown).
Baseline growth was similar across each sample type. Specifically, CFU/cm 2 were within 0.5 Log 10 units of each other (Table 2) , which also highlighted the repeatability of the system across multiple runs. Similarly, when broth samples from flow cell chambers were quantified to determine CFU/mL, growth was consistent across all runs of the flow cell system. Data showed that broth samples had 8.21 AE 0.08 Log 10 CFU/ml, which was roughly 1 Log 10 unit more than what was cultured per cm 2 on OI implant samples. TiAl6V4 alloy that was coated with TiNbN and treated with LPB did show a trend of less biofilm growth (see Table 2 ), but when compared statistically, there was no difference in CFU/cm 2 between any sample type (p ¼ 0.13).
The wash test with a badger hair brush and Dove 1 soap showed similar outcomes across each sample type ( Table 2 ). As observed in the growth data, OI samples coated with TiNbN and treated with LPB showed a trend of reduced bioburden following the wash procedure (see Table 2 ), but statistically there was no difference in CFU/cm 2 (p ¼ 0.22). Overall, the wash procedure resulted in a reduction of approximately 3 log 10 units (99.9%) for all sample types.
Biofilm Surface Coverage Pre and Post Wash
The % surface coverage analyses provided an initial indication as to how much biofilm grew on the surface of each implant (Fig. 6 ). TiAl6V4 alloy samples that were coated with TiNbN and treated with LPB had the lowest average surface coverage at 40 AE 22%. Color Buff and Satin Finish samples had 56 AE 23% and 58 AE 17% of sample surfaces covered with biofilm growth, respectively. However, the differences were not statistically significant (p ¼ 0.10).
When samples were washed using the badger hair brush procedure and imaged to determine remaining surface coverage, data showed that the TiNbN/LPB samples had approximately 5.8% surface coverage remaining. The other two samples had 0% detectable coverage. The differences were not statistically significant (p ¼ 0.16). In general, data indicated that the washing procedure was able to remove the large majority of visible bioburden regardless of material type or surface treatment. SEM data (Figs. 4 and 5 ) indicated the degree of removal on a microscopic scale.
SEM Imaging Pre and Post Wash
SEM images of positive growth (Fig. 5 ) illustrated the characteristics of the biofilms including the interaction between cells and extracellular matrix. TiNbN/LPB samples appeared to have sheet-like biofilms while the biofilms of the other two types were more plume-like.
SEM images were also collected following the wash procedure and confirmed qualitatively that the majority of bacteria had been removed. Biofilms were reduced to a degree where small clusters of bacteria remained on washed specimens (Fig. 5) . Direct counts of bacteria were performed from the SEM images and indicated that there were roughly 100-1000 cells/mm 2 , which correlated with the quantification data.
As surfaces were scanned, it was found that cells/ clusters were fairly equally distributed across each surface type. However, although only small clusters of cells remained on the surface, each of the material types had extracellular matrix components that could be identified following the wash regimen (see Fig. 5 ). In summary, data indicated that a clinically-relevant wash regimen had the ability to reduce the majority of cellular bioburden that was present.
DISCUSSION
OI implant technology provides an innovative and promising approach to address problems that can accompany prosthetic socket technology. However, infection remains a clinical concern. Multiple extremity OI implant systems are currently in use with implantation rates increasing each year. Patients who receive these implants are given instructions to wash the percutaneous skin/implant portion of their device twice daily using soap, water and a badger hair brush or similar scrubber. After a thorough literature review, it does not appear that this wash method has been assessed for its ability to remove bioburden, in particular biofilms that inherently develop at the interface. In this study, a TiAl6V4 alloy material, coated with TiNbN and treated with LPB, which is currently in use for OI implants as part of a feasibility study at the Department of Veterans Affairs Salt Lake City Health Care System, was machined and assessed to initially determine the degree to which a clinically-relevant isolate of MRSA would form biofilms on the surface. Two additional TiAl6V4 alloys and subsequent finishes that are commonly used in clinical practice and candidate material for OI devices were also assessed for comparison. There were statistically significant differences in Ra with the color buff treatment having the smoothest surface, but the level of growth and removal from each material type did not appear to be affected by differences in Ra. Contact angles were descriptive of surface wettability, but likewise did not appear to influence biofilm growth or washability.
Biofilms were grown in a flow cell system to model exchange of fluids that would be present in physiological conditions. It was hypothesized that TiNbN/LPB treatment would result in lower levels of biofilm formation based on claims of potential antimicrobial efficacy on similar materials. 13, 34 The ability of those similar materials to resist bacterial attachment and biofilm formation was not isolated and therefore microbiological evidence for the antimicrobial potential of the surface material alone is lacking. Digital image collection of stained biofilms showed a trend of less biofilm growth on this sample type. The same was found when directly quantifying the CFU/cm 2 . However, the differences were not statistically significant. Thus, the hypothesis was not supported.
It is well-known, and perhaps expected in the case of percutaneous technologies, that biofilms will develop, which is similar to the human paradigm of biofilm growth on teeth in the oral cavity. Teeth represent one of the most well-known percutaneous environments in biology that can be affected by the biofilm phenotype. In the case of percutaneous OI implant materials, in addition to assessing growth patterns, the more pressing question was whether biofilms could be readily washed/brushed off the material surface to manage bioburden-the principle behind why millions of individuals follow the practice of brushing their teeth twice daily. Therefore, the efficacy of a clinically-relevant wash procedure was assessed to determine the degree to which biofilm could be reduced/removed from the samples.
To begin assessing the efficacy of a wash procedure applied to OI implant technology, quantification data were collected following the wash procedure. The trend indicated that samples with TiNbN/LPB had a lower bioburden compared to the other two sample types. However, this was not statistically significant.
Percent surface coverage analysis was also performed following the wash regimen. Data indicated that samples coated with TiNbN/LPB had approximately 5.8% coverage remaining, which was higher than the other two sample types. This outcome was due to one of the TiNbN/LPB samples having a single stripe of biofilm growth left behind after the washing procedure. The stripe of growth was not seen by the naked eye while the wash procedure was being performed, but was picked up by the stain afterward. The data were still included in analysis so as not to bias the outcomes.
The hypothesis that washing would result in lower amounts of biofilm on TiNbN/LPB material compared to the other sample types was not supported by the quantification and surface coverage analysis data. Nevertheless, the wash procedure did reduce bioburden by greater than 99.9%, or more than 3 log 10 units. These data should be considered in clinical context. There is a "rule of thumb" that a bioburden kept below 10 5 CFU/U has reduced risk of causing an infection to develop. Although this rule of thumb is specific to planktonic bacteria and may not be directly applicable to biofilms, it can still provide a benchmark and deserves consideration. Given that the washing procedure reduced the bioburden to fewer than 10 5 CFU/ cm 2 , a daily wound hygiene protocol would be advisable over not washing at all. In addition, data suggested that washing (mechanical debridement) may have a greater impact on biofilm outcomes than surface treatment alone.
SEM images of samples post-wash confirmed what was observed by the above methods. The large majority of bioburden was removed from the surface and left behind roughly 100-1,000 cells/mm 2 . In most cases, cell clusters were observed to be resting on residual matrix material. Residual matrix components could be an important consideration both for clinical scenario and for future testing. More specifically, as biofilms develop and produce an extracellular matrix, the milieu provides a scaffold to which bacterial cells can attach and develop their three-dimensional structure. If this material remains on an implant, it may provide a docking site for residual cells or other exogenous bacteria to attach and flourish more readily. There are products on the market that specifically disrupt biofilm matrices, for example, Zimmer-Biomet's Bactisure 1 lavage solution. In future studies, this or similar product could be tested for its ability to not only disrupt biofilm, but more readily remove residual matrix material from OI implant surfaces.
Furthermore, an additional future study that would advance on the findings of this study would be to perform the same growth and wash procedures as outlined, then grow biofilms once again, wash and repeat multiple times. This would more closely model the clinical scenario of daily bioburden development, removal and assess how well the wash procedure works over time. Additionally, other orthopaedic-relevant materials, including cobalt chrome, silver, diamond-like carbon coating (DLC) and [Ti,Nb]ON, could also be assessed to determine if washability/removal of bioburden is improved. Data could likewise expand to additional bacterial isolate including coagulase negative S. aureus species, streptococci, Citrobacter species, Pseudomonas aeruginosa, and others. Lastly, a notable limitation of this study was the imprecise method for the wash procedure. Though the same technician did all tests, it is not possible to claim that all samples were washed with exactly the same force and water pressure. The same limitation exists in hygiene practice as no patient will treat an OI implant surface the same, but if a standardized debridement strategy or device were to be developed, these variations would need to be taken into consideration.
In conclusion, results supported the importance of a daily hygiene protocol at the skin/implant interface and suggested cleaning may be more important than surface treatments, at least in the context of those examined in this study. Washing material surfaces may have the ability to manage bioburden of biofilms to a degree that could be clinically acceptable.
STATEMENT OF SIGNIFICANCE
The ability of materials used in osseointegrated implant technology to resist bacterial attachment and biofilm formation, as well as the ability to wash away bioburden, has not yet been assessed in vitro. This work used a system to model physiological conditions to model biofilm growth. Results suggested that a wash regimen to remove bioburden may be equally or more important than material selection or modification. More specifically, similar to oral hygiene, mechanical removal of bioburden from those surfaces of an OI device that are exposed and accessible may help reduce risk of problems caused by the presence of bacterial biofilms.
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